Article info

Download PDFPDF
Original article
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN

Authors

  1. Correspondence to Dr Hélène Fontaine, Unité d'Hépatologie, Hôpital Cochin, 27, rue du faubourg Saint-Jacques, Paris 75014, France; helene.fontaine{at}cch.aphp.fr
View Full Text

Citation

Fontaine H, Kahi S, Chazallon C for the ANRS HB02 study group, et al
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN

Publication history

  • Received July 30, 2013
  • Revised January 23, 2014
  • Accepted January 24, 2014
  • First published February 20, 2014.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.